Editorial Commentary: Clinical management of cardiovascular disease in HIV-infected patients
Authors:
- 22 July 2017
- journal article
- editorial
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 27 (8) , 564-566
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 15 references indexed in Scilit:
- Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United StatesJAMA Cardiology, 2017
- HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial.2015
- RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS)Atherosclerosis, 2014
- HIV Replication and Immune Status Are Independent Predictors of the Risk of Myocardial Infarction in HIV-Infected IndividualsClinical Infectious Diseases, 2012
- Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected PatientsThe Journal of Infectious Diseases, 2011
- Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected menAIDS, 2010
- The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veteransJournal of General Internal Medicine, 2005
- Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infectionThe American Journal of Cardiology, 2003
- Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS, 2003
- Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study2003